These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 9777351

  • 1. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer].
    Kashkin KN, Fleĭshman EV, Chumakov PM, Perevoshchikov AG.
    Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351
    [Abstract] [Full Text] [Related]

  • 2. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer.
    Watatani M, Yoshida T, Kuroda K, Ieda S, Yasutomi M.
    Cancer; 1996 Apr 15; 77(8 Suppl):1688-93. PubMed ID: 8608563
    [Abstract] [Full Text] [Related]

  • 3. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P.
    Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152
    [Abstract] [Full Text] [Related]

  • 4. Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group.
    Eccles DM, Russell SE, Haites NE, Atkinson R, Bell DW, Gruber L, Hickey I, Kelly K, Kitchener H, Leonard R.
    Oncogene; 1992 Oct 01; 7(10):2069-72. PubMed ID: 1408149
    [Abstract] [Full Text] [Related]

  • 5. Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.
    Kobayashi M, Kawashima A, Mai M, Ooi A.
    Am J Pathol; 1996 Nov 01; 149(5):1575-84. PubMed ID: 8909247
    [Abstract] [Full Text] [Related]

  • 6. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
    Sakamoto T, Nomura N, Mori H, Wake N.
    Gynecol Oncol; 1996 Nov 01; 63(2):173-9. PubMed ID: 8910623
    [Abstract] [Full Text] [Related]

  • 7. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas.
    Cote RJ, Jhanwar SC, Novick S, Pellicer A.
    Cancer Res; 1991 Oct 01; 51(19):5410-6. PubMed ID: 1913660
    [Abstract] [Full Text] [Related]

  • 8. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
    Gerdes H, Chen Q, Elahi AH, Sircar A, Goldberg E, Winawer D, Urmacher C, Winawer SJ, Jhanwar SC.
    Anticancer Res; 1995 Oct 01; 15(1):13-24. PubMed ID: 7733622
    [Abstract] [Full Text] [Related]

  • 9. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer.
    Dalbagni G, Presti JC, Reuter VE, Zhang ZF, Sarkis AS, Fair WR, Cordon-Cardo C.
    Diagn Mol Pathol; 1993 Mar 01; 2(1):4-13. PubMed ID: 7904525
    [Abstract] [Full Text] [Related]

  • 10. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.
    Tsao SW, Mok CH, Oike K, Muto M, Goodman HM, Sheets EE, Berkowitz RS, Knapp RC, Lau CC.
    Anticancer Res; 1991 Mar 01; 11(6):1975-82. PubMed ID: 1776830
    [Abstract] [Full Text] [Related]

  • 11. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.
    Okamoto A, Sameshima Y, Yamada Y, Teshima S, Terashima Y, Terada M, Yokota J.
    Cancer Res; 1991 Oct 15; 51(20):5632-5. PubMed ID: 1913680
    [Abstract] [Full Text] [Related]

  • 12. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas.
    Campo E, de la Calle-Martin O, Miquel R, Palacin A, Romero M, Fabregat V, Vives J, Cardesa A, Yague J.
    Cancer Res; 1991 Aug 15; 51(16):4436-42. PubMed ID: 1868464
    [Abstract] [Full Text] [Related]

  • 13. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
    Saxena A, Clark WC, Robertson JT, Ikejiri B, Oldfield EH, Ali IU.
    Cancer Res; 1992 Dec 01; 52(23):6716-21. PubMed ID: 1358438
    [Abstract] [Full Text] [Related]

  • 14. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas.
    Sano T, Tsujino T, Yoshida K, Nakayama H, Haruma K, Ito H, Nakamura Y, Kajiyama G, Tahara E.
    Cancer Res; 1991 Jun 01; 51(11):2926-31. PubMed ID: 2032230
    [Abstract] [Full Text] [Related]

  • 15. Allelic deletion on chromosome 17p13.3 in early ovarian cancer.
    Phillips NJ, Ziegler MR, Radford DM, Fair KL, Steinbrueck T, Xynos FP, Donis-Keller H.
    Cancer Res; 1996 Feb 01; 56(3):606-11. PubMed ID: 8564979
    [Abstract] [Full Text] [Related]

  • 16. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM.
    Cancer Res; 1993 Jul 01; 53(13):3092-7. PubMed ID: 8319216
    [Abstract] [Full Text] [Related]

  • 17. Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma.
    Thorlacius S, Jonasdottir O, Eyfjord JE.
    Anticancer Res; 1991 Jul 01; 11(4):1501-7. PubMed ID: 1746906
    [Abstract] [Full Text] [Related]

  • 18. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
    Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenega M, Imura H, Ishizaki K.
    Cancer Res; 1993 Jan 15; 53(2):368-72. PubMed ID: 8093350
    [Abstract] [Full Text] [Related]

  • 19. Expression of p53 and 17p allelic loss in colorectal carcinoma.
    Cunningham J, Lust JA, Schaid DJ, Bren GD, Carpenter HA, Rizza E, Kovach JS, Thibodeau SN.
    Cancer Res; 1992 Apr 01; 52(7):1974-80. PubMed ID: 1551126
    [Abstract] [Full Text] [Related]

  • 20. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH, Bayona W, Koslow M, Newcomb EW.
    Cancer Res; 1992 Mar 15; 52(6):1427-33. PubMed ID: 1347252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.